Neuromodulation Market by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic, Polymeric, Ceramic), Application (Epilepsy, Tremor, Incontinence, Depression, Chronic Pain Management, Failed Back Syndrome, Dystonia, Gastroparesis, Parkinson’s Disease, Urine Incontinence, Fecal Incontinence, Other)- Global Opportunity Analysis and Industry Forecast, 2020 – 2030

Neuromodulation Market

Industry:  Life Sciences & Healthcare | Publish Date: Jul 2020 | No of Pages:  487 | No. Tables:  276 | No. Figures:  246

Market Definition:

The global Neuromodulation Market size was valued at USD 5.90 billion in 2019 and is predicted to reach USD 22.19 billion by 2030, with a CAGR of 12.8% from 2020-2030.

Neuromodulation is controlled electric simulation of the central nervous system or the peripheral nerve, to manage neural activity in the patient’s suffering from neurological disorders such as cerebrovascular diseases, Alzheimer disease, epilepsy, Parkinson's, as well as those caused by bacterial, viral, and fungal infections. The electrodes are directly placed in the brain or peripheral nerves or spinal cord, and pulse generators are implanted under the skin for better results.

Neuromodulation are controlled, reversible, and targeted therapies; as a result, they have minimal to no side-effects on human body as compared to irreversible treatment options used to treat neurological disorders. There are no drug dependencies associated with neuromodulation therapies, hence there is no fear for drug addiction. Furthermore, in some cases, neuromodulation has proved to be more cost-effective than conventional treatment options. These benefits offered by neuromodulation, are projected to propagate the growth of global neuromodulation market, in coming future.

Market Dynamics and Trends:

According to the Public Health Challenges report presented by the World Health Organization in 2019, approximately 6.8 million people die every year due to neurological disorders. 1 billion people are affected by neurological disorder worldwide, of which 50 million people suffer from epilepsy and 24 million from Alzheimer disease.

The increasing prevalence of neurological disorders worldwide, augments the demand for proper healthcare facilities and advanced treatment options to cope with neurological disorders, thereby propelling the growth of global neuromodulation market.

However, factors such as strict policies for product approval, and lack of skilled healthcare professionals are expected to impede the growth of neuromodulation market.

Moreover, factors such as increasing geriatric population prone to neurological disorders, growing awareness regarding safety and efficiency of neuromodulation, as well as increasing investments by public and private sectors in clinical R&D activities for technological advancements, are expected to propagate the growth of global neuromodulation market throughout the forecast period.

 

Market Segmentations and Scope of the Study:

The global neuromodulation market share has been analyzed based on technology, application, biomaterial, and geography. Based on technology, the neuromodulation market is classified into internal neuromodulation and external neuromodulation. The internal neuromodulation segment is sub segmented into Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, and other. The external neuromodulation segment is further divided into Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation. Based on application, the neuromodulation market is fragmented into chronic pain management, failed back syndrome, epilepsy, tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, Parkinson's disease, Obsessive-Compulsive Disorder, migraine, and other. Based on biomaterial, the neuromodulation market is divided into metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

 

Geographical Analysis:

North America is anticipated to account for major market share in the global neuromodulation market throughout the forecast period, owing to well-established healthcare infrastructures and medical laboratories, increased prevalence of neurological disorders leading to higher adoption of the neuromodulation and upsurge in clinical trials aimed at technological advancements.

Asia Pacific is estimated to show tremendous growth in the global neuromodulation market with substantially increasing market share over the forecast period, owing to rise in government initiatives to treat chronic neurological disorders, and increase in the number of product launches.

 

Competitive Landscape:

The neuromodulation market is highly competitive and consists of various market players. Some of the major market players include Abbott, Medtronic, Boston Scientific Corporation, Cochlear Ltd., Cyberonics Inc., Sonova, Nevro Corp., Advanced Bionics AG, Integer Holdings Corporation, Neuronetics, NeuroPace Inc., Synapse Biomedical Inc., Magstim, NeuroSigma Inc., LivaNova PLC, Soterix Medical Inc., ALEVA NEUROTHERAPEUTICS SA, ReShape Lifesciences Inc., Bioness Inc., DynaMD, BioAlps, MED-EL, The Axonics SNM System, Johnson & Johnson Services Inc., LABORIE, Stimwave LLC, Functional Neuromodulation Ltd., and Biegler GmbH among others.

An upsurge in R&D activities and advancement in product technologies along with increasing number of FDA approvals, stimulates the growth of global neuromodulation market.

For instance, in September 2019, Functional Neuromodulation ltd., one of the major players in the global neuromodulation market, announced that it has initiated a pivot clinical trial to assess Deep Brain Stimulation (DBS) in patients suffering from mild Alzheimer’s Disease. The global Advance-II study, evaluates the safety and efficacy of stimulation for the fornix (DBS-f)—a major inflow and output pathway in the brain’s memory circuit. Research suggests that this is an area affected in the early development of Alzheimer’s disease.

In January 2020, Abbott, one of the major players in the global neuromodulation market, announced that it has received FDA approval for Abbott’s expanded Infinity Deep Brain Stimulation (DBS) system to treat Parkinson’s disease. The Infinity DBS system can target the area of brain called GPi (internal Globus Pallidus) that plays vital role in motor functions, hence assisting in improving the symptoms of Parkinson's disease that are not efficiently controlled by medication. Abbott’s infinity DBS system is the first-ever system that is compatible with iOS platform and Bluetooth wireless technology, hence proving to be a patient-centric innovation technology that can streamline the programming process using Abbott's new Informity with an iPad mini device.

In January 2020, Abbott announced that its BurstDR micrOdosing stimuLation in De-novo patients (BOLD) study reinforce the benefits of XR recharge-free neurostimulation system in people suffering from chronic pain. BOLD study claims that BurstD stimulation waveform reduced the PCS (Pain Catastrophizing Scale Scores), decreasing the negative psychological effects associated with chronic pain at six-month follow up by 62%.

Moreover, in March 2020, Neuronetics Inc., one of the major players in the global neuromodulation market, announced that NeuroStar Advanced Therapy Transcranial Magnetic Stimulation (TMS) system has been granted the breakthrough designation for the treatment of bipolar depression, by the US Food and Drug Administration.

KEY BENEFITS:

  • The neuromodulation market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.

  • The study comprises a deep dive analysis of the neuromodulation market trend including the current and future trends for depicting the prevalent investment pockets in the market.

  • The information related to key drivers, restraints and opportunities and their impact on the neuromodulation market is provided in the report.

  • The competitive analysis of the market players along with their market share in the global neuromodulation market.

  • The SWOT analysis and Porters Five Forces model is elaborated in the study of neuromodulation market.

  • Value chain analysis in the neuromodulation market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Technology

  • Internal Neuromodulation

    • Deep Brain Stimulation

    • Sacral Nerve Stimulation

    • Vagus Nerve Stimulation

    • Spinal Cord Stimulation

    • Other

  • External Neuromodulation

    • Transcutaneous Electrical Nerve Stimulation

    • Transcranial Magnetic Stimulation

By Biomaterial

  • Metallic Biomaterials

  • Polymeric Biomaterials

  • Ceramic Biomaterials

By Application

  • Chronic Pain Management

  • Failed Back syndrome

  • Epilepsy

  • Tremor

  • Urinary and Fecal Incontinence

  • Depression

  • Dystonia

  • Gastroparesis

  • Parkinson's Disease

  • Obsessive-Compulsive Disorder

  • Migraine

  • Other 

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Rest of Europe

  • Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Malaysia

    • Rest of Asia-Pacific

  • RoW

    • Israel

    • Saudi Arabia

    • South Africa

    • Brazil

    • Remaining countries

REPORT SCOPE AND SEGMENTATION:

Parameters

Details

Analysis Period

2019–2030

Base Year Considered

2020

Forecast Period

2020–2030

Market Size Estimation

Billion (USD)

Market Segmentation

By Technology (Internal Neuromodulation, External Neuromodulation) By Application (Failed Back Syndrome, Chronic Pain, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, Migraine) By Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials)

Geographical Segmentation

North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Malaysia, Rest of APAC), Rest of the World (Brazil, Israel, Saudi Arabia, South Africa, Remaining Countries)

Companies Profiled

Abbott, Medtronic, Boston Scientific Corporation, Cochlear Ltd., Cyberonics Inc., Sonova, Nevro Corp., Advanced Bionics AG, Integer Holdings Corporation, Neuronetics, NeuroPace Inc., Synapse Biomedical Inc., Magstim, NeuroSigma Inc., LivaNova PLC, Soterix Medical Inc., Aleva Neurotherapeutics Sa, ReShape Lifesciences Inc., Bioness Inc., DynaMD, BioAlps, MED-EL, The Axonics SNM System, Johnson & Johnson Services Inc., Laborie, Stimwave LLC, Functional Neuromodulation Ltd., and Biegler GmbH.

column chart pie chart

1.    INTRODUCTION

1.1.           REPORT DESCRIPTION

1.2.           Research Methodology

1.2.1             Secondary Research

1.2.2             Data Analysis Framework

1.2.3             Market size estimation

1.2.4             Forecasting

1.2.5             Primary Research and Data Validation

2.    MARKET SNAPSHOT, 2019-2030 Million USD

2.1.           MARKET SNAPSHOT

3.    PORTER’S FIVE FORCE MODEL ANALYSIS

4.    MARKET DYNAMICS

4.1.           GROWTH DRIVERS

4.1.1             DRIVER 1

4.1.2             DRIVER 2

4.1.3             DRIVER 3

4.1.4             DRIVER 4

4.2.           CHALLENGES

4.2.1             CHALLENGE 1

4.2.2             CHALLENGE 2

4.3.           OPPORTUNITIES

4.3.1             OPPORTUNITY 1

4.3.2             OPPORTUNITY 2

5.    Global  Neuromodulation Market, By Technology

5.1.           Overview

5.2.           Internal Neuromodulation

5.2.1             Global Internal Neuromodulation Market, By Technology

5.2.1.1        Deep Brain Stimulation Market, By Region

5.2.1.1.1        North America Deep Brain Stimulation Market, By Country

5.2.1.1.2        Europe Deep Brain Stimulation Market, By Country

5.2.1.1.3        Asia-Pacific Deep Brain Stimulation Market, By Country

5.2.1.1.4        Rest of World Deep Brain Stimulation Market, By Country

5.2.1.2        Sacral nerve Stimulation Market, By Region

5.2.1.2.1        North America Sacral nerve Stimulation Market, By Country

5.2.1.2.2        Europe Sacral nerve Stimulation Market, By Country

5.2.1.2.3        Asia-Pacific Sacral nerve Stimulation Market, By Country

5.2.1.2.4        Rest of World Sacral nerve Stimulation Market, By Country

5.2.1.3        Spinal Cord Stimulation Market, By Region

5.2.1.3.1        North America Spinal Cord Stimulation Market, By Country

5.2.1.3.2        Europe Spinal Cord Stimulation Market, By Country

5.2.1.3.3        Asia-Pacific Spinal Cord Stimulation Market, By Country

5.2.1.3.4        Rest of World Spinal Cord Stimulation Market, By Country

5.2.1.4        Vagus Nerve Stimulation Market, By Region

5.2.1.4.1        North America Vagus Nerve Stimulation Market, By Country

5.2.1.4.2        Europe Vagus Nerve Stimulation Market, By Country

5.2.1.4.3        Asia-Pacific Vagus Nerve Stimulation Market, By Country

5.2.1.4.4        Rest of World Vagus Nerve Stimulation Market, By Country

5.2.1.5        Other Neuromodulation Market, By Region

5.2.1.5.1        North America Other Neuromodulation Market, By Country

5.2.1.5.2        Europe Other Neuromodulation Market, By Country

5.2.1.5.3        Asia-Pacific Other Neuromodulation Market, By Country

5.2.1.5.4        Rest of World Other Neuromodulation Market, By Country

5.2.2             Internal Neuromodulation Market, By Region

5.2.2.1        North America Internal Neuromodulation Market, By Country

5.2.2.2        Europe Internal Neuromodulation Market, By Country

5.2.2.3        Asia-Pacific Internal Neuromodulation Market, By Country

5.2.2.4        Rest of World Internal Neuromodulation Market, By Country

5.3.           External Neuromodulation

5.3.1             Global External Neuromodulation Market, By Technology

5.3.1.1        Transcutaneous Electrical Nerve Stimulation Market, By Region

5.3.1.1.1        North America Transcutaneous Electrical Nerve Stimulation Market, By Country

5.3.1.1.2        Europe Transcutaneous Electrical Nerve Stimulation Market, By Country

5.3.1.1.3        Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market, By Country

5.3.1.1.4        Rest of World Transcutaneous Electrical Nerve Stimulation Market, By Country

5.3.1.2        Transcranial Magnetic Stimulation Market, By Region

5.3.1.2.1        North America Transcranial Magnetic Stimulation Market, By Country

5.3.1.2.2        Europe Transcranial Magnetic Stimulation Market, By Country

5.3.1.2.3        Asia-Pacific Transcranial Magnetic Stimulation Market, By Country

5.3.1.2.4        Rest of World Transcranial Magnetic Stimulation Market, By Country

5.3.2             External Neuromodulation Market, By Region

5.3.2.1        North America External Neuromodulation Market, By Country

5.3.2.2        Europe External Neuromodulation Market, By Country

5.3.2.3        Asia-Pacific External Neuromodulation Market, By Country

5.3.2.4        Rest of World External Neuromodulation Market, By Country

6.    Global  Neuromodulation Market, By Application

6.1.           Overview

6.2.           Failed Back Syndrome

6.2.1             Failed Back Syndrome Market, By Region

6.2.1.1        North America Failed Back Syndrome Market, By Country

6.2.1.2        Europe Failed Back Syndrome Market, By Country

6.2.1.3        Asia-Pacific Failed Back Syndrome Market, By Country

6.2.1.4        Rest of World Failed Back Syndrome Market, By Country

6.3.           Chronic Pain

6.3.1             Chronic Pain Market, By Region

6.3.1.1        North America Chronic Pain Market, By Country

6.3.1.2        Europe Chronic Pain Market, By Country

6.3.1.3        Asia-Pacific Chronic Pain Market, By Country

6.3.1.4        Rest of World Chronic Pain Market, By Country

6.4.           Epilepsy

6.4.1             Epilepsy Market, By Region

6.4.1.1        North America Epilepsy Market, By Country

6.4.1.2        Europe Epilepsy Market, By Country

6.4.1.3        Asia-Pacific Epilepsy Market, By Country

6.4.1.4        Rest of World Epilepsy Market, By Country

6.5.           Essential Tremor

6.5.1             Essential Tremor Market, By Region

6.5.1.1        North America Essential Tremor Market, By Country

6.5.1.2        Europe Essential Tremor Market, By Country

6.5.1.3        Asia-Pacific Essential Tremor Market, By Country

6.5.1.4        Rest of World Essential Tremor Market, By Country

6.6.           Urinary and Fecal Incontinence

6.6.1             Urinary and Fecal Incontinence Market, By Region

6.6.1.1        North America Urinary and Fecal Incontinence Market, By Country

6.6.1.2        Europe Urinary and Fecal Incontinence Market, By Country

6.6.1.3        Asia-Pacific Urinary and Fecal Incontinence Market, By Country

6.6.1.4        Rest of World Urinary and Fecal Incontinence Market, By Country

6.7.           Depression

6.7.1             Depression Market, By Region

6.7.1.1        North America Depression Market, By Country

6.7.1.2        Europe Depression Market, By Country

6.7.1.3        Asia-Pacific Depression Market, By Country

6.7.1.4        Rest of World Depression Market, By Country

6.8.           Dystonia

6.8.1             Dystonia Market, By Region

6.8.1.1        North America Dystonia Market, By Country

6.8.1.2        Europe Dystonia Market, By Country

6.8.1.3        Asia-Pacific Dystonia Market, By Country

6.8.1.4        Rest of World Dystonia Market, By Country

6.9.           Gastroparesis

6.9.1             Gastroparesis Market, By Region

6.9.1.1        North America Gastroparesis Market, By Country

6.9.1.2        Europe Gastroparesis Market, By Country

6.9.1.3        Asia-Pacific Gastroparesis Market, By Country

6.9.1.4        Rest of World Gastroparesis Market, By Country

6.10.         Parkinson's Disease

6.10.1           Parkinson's Disease Market, By Region

6.10.1.1      North America Parkinson's Disease Market, By Country

6.10.1.2      Europe Parkinson's Disease Market, By Country

6.10.1.3      Asia-Pacific Parkinson's Disease Market, By Country

6.10.1.4      Rest of World Parkinson's Disease Market, By Country

6.11.         Migraine

6.11.1           Migraine Market, By Region

6.11.1.1      North America Migraine Market, By Country

6.11.1.2      Europe Migraine Market, By Country

6.11.1.3      Asia-Pacific Migraine Market, By Country

6.11.1.4      Rest of World Migraine Market, By Country

7.    Global  Neuromodulation Market, By Biomaterial

7.1.           Overview

7.2.           Ceramics Biomaterials

7.2.1             Ceramics Biomaterials Market, By Region

7.2.1.1        North America Ceramics Biomaterials Market, By Country

7.2.1.2        Europe Ceramics Biomaterials Market, By Country

7.2.1.3        Asia-Pacific Ceramics Biomaterials Market, By Country

7.2.1.4        Rest of World Ceramics Biomaterials Market, By Country

7.3.           Metallic Biomaterials

7.3.1             Metallic Biomaterials Market, By Region

7.3.1.1        North America Metallic Biomaterials Market, By Country

7.3.1.2        Europe Metallic Biomaterials Market, By Country

7.3.1.3        Asia-Pacific Metallic Biomaterials Market, By Country

7.3.1.4        Rest of World Metallic Biomaterials Market, By Country

7.4.           Polymeric Biomaterials

7.4.1             Polymeric Biomaterials Market, By Region

7.4.1.1        North America Polymeric Biomaterials Market, By Country

7.4.1.2        Europe Polymeric Biomaterials Market, By Country

7.4.1.3        Asia-Pacific Polymeric Biomaterials Market, By Country

7.4.1.4        Rest of World Polymeric Biomaterials Market, By Country

8.    Global  Neuromodulation Market, By Region

8.1.           Overview

8.2.           North America

8.2.1             North America Neuromodulation Market, By Technology

8.2.1.1        North America  Internal Neuromodulation Market, By Technology

8.2.1.2        North America  External Neuromodulation Market, By Technology

8.2.2             North America Neuromodulation Market, By Application

8.2.3             North America Neuromodulation Market, By Biomaterial

8.2.4             North America Neuromodulation, Market By Country

8.2.4.1        U.S.

8.2.4.1.1        U.S. Neuromodulation Market, By Technology

8.2.4.1.1.1. U.S. Internal Neuromodulation Market, By Technology

8.2.4.1.1.2. U.S. External Neuromodulation Market, By Technology

8.2.4.1.2        U.S. Neuromodulation Market, By Application

8.2.4.1.3        U.S. Neuromodulation Market, By Biomaterial

8.2.4.2        Canada

8.2.4.2.1        Canada Neuromodulation Market, By Technology

8.2.4.2.1.1. Canada Internal Neuromodulation Market, By Technology

8.2.4.2.1.2. Canada External Neuromodulation Market, By Technology

8.2.4.2.2        Canada Neuromodulation Market, By Application

8.2.4.2.3        Canada Neuromodulation Market, By Biomaterial

8.2.4.3        Mexico

8.2.4.3.1        Mexico Neuromodulation Market, By Technology

8.2.4.3.1.1. Mexico Internal Neuromodulation Market, By Technology

8.2.4.3.1.2. Mexico External Neuromodulation Market, By Technology

8.2.4.3.2        Mexico Neuromodulation Market, By Application

8.2.4.3.3        Mexico Neuromodulation Market, By Biomaterial

8.3.           Europe

8.3.1             Europe Neuromodulation Market, By Technology

8.3.1.1        Europe  Internal Neuromodulation Market, By Technology

8.3.1.2        Europe  External Neuromodulation Market, By Technology

8.3.2             Europe Neuromodulation Market, By Application

8.3.3             Europe Neuromodulation Market, By Biomaterial

8.3.4             Europe Neuromodulation, Market By Country

8.3.4.1        Germany

8.3.4.1.1        Germany Neuromodulation Market, By Technology

8.3.4.1.1.1. Germany Internal Neuromodulation Market, By Technology

8.3.4.1.1.2. Germany External Neuromodulation Market, By Technology

8.3.4.1.2        Germany Neuromodulation Market, By Application

8.3.4.1.3        Germany Neuromodulation Market, By Biomaterial

8.3.4.2        UK

8.3.4.2.1        UK Neuromodulation Market, By Technology

8.3.4.2.1.1. UK Internal Neuromodulation Market, By Technology

8.3.4.2.1.2. UK External Neuromodulation Market, By Technology

8.3.4.2.2        UK Neuromodulation Market, By Application

8.3.4.2.3        UK Neuromodulation Market, By Biomaterial

8.3.4.3        France

8.3.4.3.1        France Neuromodulation Market, By Technology

8.3.4.3.1.1. France Internal Neuromodulation Market, By Technology

8.3.4.3.1.2. France External Neuromodulation Market, By Technology

8.3.4.3.2        France Neuromodulation Market, By Application

8.3.4.3.3        France Neuromodulation Market, By Biomaterial

8.3.4.4        Italy

8.3.4.4.1        Italy Neuromodulation Market, By Technology

8.3.4.4.1.1. Italy Internal Neuromodulation Market, By Technology

8.3.4.4.1.2. Italy External Neuromodulation Market, By Technology

8.3.4.4.2        Italy Neuromodulation Market, By Application

8.3.4.4.3        Italy Neuromodulation Market, By Biomaterial

8.3.4.5        Spain

8.3.4.5.1        Spain Neuromodulation Market, By Technology

8.3.4.5.1.1. Spain Internal Neuromodulation Market, By Technology

8.3.4.5.1.2. Spain External Neuromodulation Market, By Technology

8.3.4.5.2        Spain Neuromodulation Market, By Application

8.3.4.5.3        Spain Neuromodulation Market, By Biomaterial

8.3.4.6        Rest of Europe

8.3.4.6.1        Rest of Europe Neuromodulation Market, By Technology

8.3.4.6.1.1. Rest of Europe Internal Neuromodulation Market, By Technology

8.3.4.6.1.2. Rest of Europe External Neuromodulation Market, By Technology

8.3.4.6.2        Rest of Europe Neuromodulation Market, By Application

8.3.4.6.3        Rest of Europe Neuromodulation Market, By Biomaterial

8.4.           Asia-Pacific

8.4.1             Asia-Pacific Neuromodulation Market, By Technology

8.4.1.1        Asia-Pacific  Internal Neuromodulation Market, By Technology

8.4.1.2        Asia-Pacific  External Neuromodulation Market, By Technology

8.4.2             Asia-Pacific Neuromodulation Market, By Application

8.4.3             Asia-Pacific Neuromodulation Market, By Biomaterial

8.4.4             Asia-Pacific Neuromodulation, Market By Country

8.4.4.1        China

8.4.4.1.1        China Neuromodulation Market, By Technology

8.4.4.1.1.1. China Internal Neuromodulation Market, By Technology

8.4.4.1.1.2. China External Neuromodulation Market, By Technology

8.4.4.1.2        China Neuromodulation Market, By Application

8.4.4.1.3        China Neuromodulation Market, By Biomaterial

8.4.4.2        India

8.4.4.2.1        India Neuromodulation Market, By Technology

8.4.4.2.1.1. India Internal Neuromodulation Market, By Technology

8.4.4.2.1.2. India External Neuromodulation Market, By Technology

8.4.4.2.2        India Neuromodulation Market, By Application

8.4.4.2.3        India Neuromodulation Market, By Biomaterial

8.4.4.3        Japan

8.4.4.3.1        Japan Neuromodulation Market, By Technology

8.4.4.3.1.1. Japan Internal Neuromodulation Market, By Technology

8.4.4.3.1.2. Japan External Neuromodulation Market, By Technology

8.4.4.3.2        Japan Neuromodulation Market, By Application

8.4.4.3.3        Japan Neuromodulation Market, By Biomaterial

8.4.4.4        South Korea

8.4.4.4.1        South Korea Neuromodulation Market, By Technology

8.4.4.4.1.1. South Korea Internal Neuromodulation Market, By Technology

8.4.4.4.1.2. South Korea External Neuromodulation Market, By Technology

8.4.4.4.2        South Korea Neuromodulation Market, By Application

8.4.4.4.3        South Korea Neuromodulation Market, By Biomaterial

8.4.4.5        Malaysia

8.4.4.5.1        Malaysia Neuromodulation Market, By Technology

8.4.4.5.1.1. Malaysia Internal Neuromodulation Market, By Technology

8.4.4.5.1.2. Malaysia External Neuromodulation Market, By Technology

8.4.4.5.2        Malaysia Neuromodulation Market, By Application

8.4.4.5.3        Malaysia Neuromodulation Market, By Biomaterial

8.4.4.6        Rest of Asia-Pacific

8.4.4.6.1        Rest of Asia-Pacific Neuromodulation Market, By Technology

8.4.4.6.1.1. Rest of Asia-Pacific Internal Neuromodulation Market, By Technology

8.4.4.6.1.2. Rest of Asia-Pacific External Neuromodulation Market, By Technology

8.4.4.6.2        Rest of Asia-Pacific Neuromodulation Market, By Application

8.4.4.6.3        Rest of Asia-Pacific Neuromodulation Market, By Biomaterial

8.5.           Rest of World

8.5.1             Rest of World Neuromodulation Market, By Technology

8.5.1.1        Rest of World  Internal Neuromodulation Market, By Technology

8.5.1.2        Rest of World  External Neuromodulation Market, By Technology

8.5.2             Rest of World Neuromodulation Market, By Application

8.5.3             Rest of World Neuromodulation Market, By Biomaterial

8.5.4             Rest of World Neuromodulation, Market By Country

8.5.4.1        Brazil

8.5.4.1.1        Brazil Neuromodulation Market, By Technology

8.5.4.1.1.1. Brazil Internal Neuromodulation Market, By Technology

8.5.4.1.1.2. Brazil External Neuromodulation Market, By Technology

8.5.4.1.2        Brazil Neuromodulation Market, By Application

8.5.4.1.3        Brazil Neuromodulation Market, By Biomaterial

8.5.4.2        Israel

8.5.4.2.1        Israel Neuromodulation Market, By Technology

8.5.4.2.1.1. Israel Internal Neuromodulation Market, By Technology

8.5.4.2.1.2. Israel External Neuromodulation Market, By Technology

8.5.4.2.2        Israel Neuromodulation Market, By Application

8.5.4.2.3        Israel Neuromodulation Market, By Biomaterial

8.5.4.3        Saudi Arabia

8.5.4.3.1        Saudi Arabia Neuromodulation Market, By Technology

8.5.4.3.1.1. Saudi Arabia Internal Neuromodulation Market, By Technology

8.5.4.3.1.2. Saudi Arabia External Neuromodulation Market, By Technology

8.5.4.3.2        Saudi Arabia Neuromodulation Market, By Application

8.5.4.3.3        Saudi Arabia Neuromodulation Market, By Biomaterial

8.5.4.4        South Africa

8.5.4.4.1        South Africa Neuromodulation Market, By Technology

8.5.4.4.1.1. South Africa Internal Neuromodulation Market, By Technology

8.5.4.4.1.2. South Africa External Neuromodulation Market, By Technology

8.5.4.4.2        South Africa Neuromodulation Market, By Application

8.5.4.4.3        South Africa Neuromodulation Market, By Biomaterial

8.5.4.5        Remaining Countries

8.5.4.5.1        Remaining Countries Neuromodulation Market, By Technology

8.5.4.5.1.1. Remaining Countries Internal Neuromodulation Market, By Technology

8.5.4.5.1.2. Remaining Countries External Neuromodulation Market, By Technology

8.5.4.5.2        Remaining Countries Neuromodulation Market, By Application

8.5.4.5.3        Remaining Countries Neuromodulation Market, By Biomaterial

9.    COMPANY PROFILES

9.1.           Aleva Neurotherapeutics SA

9.1.1             COMPANY OVERVIEW

9.1.2             COMPANY SNAPSHOT

9.1.3             OPERATING BUSINESS SEGMENTS

9.1.4             PRODUCT PORTFOLIO

9.1.5             BUSINESS PERFORMANCE

9.1.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.2.           BioControl Medical

9.2.1             COMPANY OVERVIEW

9.2.2             COMPANY SNAPSHOT

9.2.3             OPERATING BUSINESS SEGMENTS

9.2.4             PRODUCT PORTFOLIO

9.2.5             BUSINESS PERFORMANCE

9.2.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.3.           Bioness Inc.

9.3.1             COMPANY OVERVIEW

9.3.2             COMPANY SNAPSHOT

9.3.3             OPERATING BUSINESS SEGMENTS

9.3.4             PRODUCT PORTFOLIO

9.3.5             BUSINESS PERFORMANCE

9.3.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.4.           Boston Scientific Corporation

9.4.1             COMPANY OVERVIEW

9.4.2             COMPANY SNAPSHOT

9.4.3             OPERATING BUSINESS SEGMENTS

9.4.4             PRODUCT PORTFOLIO

9.4.5             BUSINESS PERFORMANCE

9.4.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.5.           EnteroMedics Inc.

9.5.1             COMPANY OVERVIEW

9.5.2             COMPANY SNAPSHOT

9.5.3             OPERATING BUSINESS SEGMENTS

9.5.4             PRODUCT PORTFOLIO

9.5.5             BUSINESS PERFORMANCE

9.5.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.6.           LivaNova PLC

9.6.1             COMPANY OVERVIEW

9.6.2             COMPANY SNAPSHOT

9.6.3             OPERATING BUSINESS SEGMENTS

9.6.4             PRODUCT PORTFOLIO

9.6.5             BUSINESS PERFORMANCE

9.6.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.7.           Medtronic plc

9.7.1             COMPANY OVERVIEW

9.7.2             COMPANY SNAPSHOT

9.7.3             OPERATING BUSINESS SEGMENTS

9.7.4             PRODUCT PORTFOLIO

9.7.5             BUSINESS PERFORMANCE

9.7.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.8.           NeuroPace, Inc.

9.8.1             COMPANY OVERVIEW

9.8.2             COMPANY SNAPSHOT

9.8.3             OPERATING BUSINESS SEGMENTS

9.8.4             PRODUCT PORTFOLIO

9.8.5             BUSINESS PERFORMANCE

9.8.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.9.           Nevro Corporation

9.9.1             COMPANY OVERVIEW

9.9.2             COMPANY SNAPSHOT

9.9.3             OPERATING BUSINESS SEGMENTS

9.9.4             PRODUCT PORTFOLIO

9.9.5             BUSINESS PERFORMANCE

9.9.6             KEY STRATEGIC MOVES AND DEVELOPMENT

9.10.         St. Jude Medical, Inc.

9.10.1           COMPANY OVERVIEW

9.10.2           COMPANY SNAPSHOT

9.10.3           OPERATING BUSINESS SEGMENTS

9.10.4           PRODUCT PORTFOLIO

9.10.5           BUSINESS PERFORMANCE

9.10.6           KEY STRATEGIC MOVES AND DEVELOPMENT

LIST OF TABLES

TABLE 1.         Global  Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 2.         Global Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 3.         Deep Brain Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 4.         North America Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 5.         Europe Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 6.         Asia-Pacific Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 7.         Rest of World Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 8.         Sacral nerve Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 9.         North America Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 10.       Europe Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 11.       Asia-Pacific Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 12.       Rest of World Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 13.       Spinal Cord Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 14.       North America Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 15.       Europe Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 16.       Asia-Pacific Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 17.       Rest of World Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 18.       Vagus Nerve Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 19.       North America Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 20.       Europe Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 21.       Asia-Pacific Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 22.       Rest of World Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 23.       Other Neuromodulation Market Value, By Region, 2019-2030, Million USD

TABLE 24.       North America Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 25.       Europe Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 26.       Asia-Pacific Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 27.       Rest of World Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 28.       Internal Neuromodulation Market Value, By Region, 2019-2030, Million USD

TABLE 29.       North America Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 30.       Europe Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 31.       Asia-Pacific Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 32.       Rest of World Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 33.       Global External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 34.       Transcutaneous Electrical Nerve Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 35.       North America Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 36.       Europe Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 37.       Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 38.       Rest of World Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 39.       Transcranial Magnetic Stimulation Market Value, By Region, 2019-2030, Million USD

TABLE 40.       North America Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 41.       Europe Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 42.       Asia-Pacific Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 43.       Rest of World Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

TABLE 44.       External Neuromodulation Market Value, By Region, 2019-2030, Million USD

TABLE 45.       North America External Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 46.       Europe External Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 47.       Asia-Pacific External Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 48.       Rest of World External Neuromodulation Market Value, By Country, 2019-2030, Million USD

TABLE 49.       Global  Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 50.       Failed Back Syndrome Market Value, By Region, 2019-2030, Million USD

TABLE 51.       North America Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 52.       Europe Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 53.       Asia-Pacific Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 54.       Rest of World Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

TABLE 55.       Chronic Pain Market Value, By Region, 2019-2030, Million USD

TABLE 56.       North America Chronic Pain Market Value, By Country, 2019-2030, Million USD

TABLE 57.       Europe Chronic Pain Market Value, By Country, 2019-2030, Million USD

TABLE 58.       Asia-Pacific Chronic Pain Market Value, By Country, 2019-2030, Million USD

TABLE 59.       Rest of World Chronic Pain Market Value, By Country, 2019-2030, Million USD

TABLE 60.       Epilepsy Market Value, By Region, 2019-2030, Million USD

TABLE 61.       North America Epilepsy Market Value, By Country, 2019-2030, Million USD

TABLE 62.       Europe Epilepsy Market Value, By Country, 2019-2030, Million USD

TABLE 63.       Asia-Pacific Epilepsy Market Value, By Country, 2019-2030, Million USD

TABLE 64.       Rest of World Epilepsy Market Value, By Country, 2019-2030, Million USD

TABLE 65.       Essential Tremor Market Value, By Region, 2019-2030, Million USD

TABLE 66.       North America Essential Tremor Market Value, By Country, 2019-2030, Million USD

TABLE 67.       Europe Essential Tremor Market Value, By Country, 2019-2030, Million USD

TABLE 68.       Asia-Pacific Essential Tremor Market Value, By Country, 2019-2030, Million USD

TABLE 69.       Rest of World Essential Tremor Market Value, By Country, 2019-2030, Million USD

TABLE 70.       Urinary and Fecal Incontinence Market Value, By Region, 2019-2030, Million USD

TABLE 71.       North America Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

TABLE 72.       Europe Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

TABLE 73.       Asia-Pacific Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

TABLE 74.       Rest of World Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

TABLE 75.       Depression Market Value, By Region, 2019-2030, Million USD

TABLE 76.       North America Depression Market Value, By Country, 2019-2030, Million USD

TABLE 77.       Europe Depression Market Value, By Country, 2019-2030, Million USD

TABLE 78.       Asia-Pacific Depression Market Value, By Country, 2019-2030, Million USD

TABLE 79.       Rest of World Depression Market Value, By Country, 2019-2030, Million USD

TABLE 80.       Dystonia Market Value, By Region, 2019-2030, Million USD

TABLE 81.       North America Dystonia Market Value, By Country, 2019-2030, Million USD

TABLE 82.       Europe Dystonia Market Value, By Country, 2019-2030, Million USD

TABLE 83.       Asia-Pacific Dystonia Market Value, By Country, 2019-2030, Million USD

TABLE 84.       Rest of World Dystonia Market Value, By Country, 2019-2030, Million USD

TABLE 85.       Gastroparesis Market Value, By Region, 2019-2030, Million USD

TABLE 86.       North America Gastroparesis Market Value, By Country, 2019-2030, Million USD

TABLE 87.       Europe Gastroparesis Market Value, By Country, 2019-2030, Million USD

TABLE 88.       Asia-Pacific Gastroparesis Market Value, By Country, 2019-2030, Million USD

TABLE 89.       Rest of World Gastroparesis Market Value, By Country, 2019-2030, Million USD

TABLE 90.       Parkinson's Disease Market Value, By Region, 2019-2030, Million USD

TABLE 91.       North America Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

TABLE 92.       Europe Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

TABLE 93.       Asia-Pacific Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

TABLE 94.       Rest of World Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

TABLE 95.       Migraine Market Value, By Region, 2019-2030, Million USD

TABLE 96.       North America Migraine Market Value, By Country, 2019-2030, Million USD

TABLE 97.       Europe Migraine Market Value, By Country, 2019-2030, Million USD

TABLE 98.       Asia-Pacific Migraine Market Value, By Country, 2019-2030, Million USD

TABLE 99.       Rest of World Migraine Market Value, By Country, 2019-2030, Million USD

TABLE 100.    Global  Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 101.    Ceramics Biomaterials Market Value, By Region, 2019-2030, Million USD

TABLE 102.    North America Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 103.    Europe Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 104.    Asia-Pacific Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 105.    Rest of World Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 106.    Metallic Biomaterials Market Value, By Region, 2019-2030, Million USD

TABLE 107.    North America Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 108.    Europe Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 109.    Asia-Pacific Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 110.    Rest of World Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 111.    Polymeric Biomaterials Market Value, By Region, 2019-2030, Million USD

TABLE 112.    North America Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 113.    Europe Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 114.    Asia-Pacific Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 115.    Rest of World Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

TABLE 116.    Global  Neuromodulation Market Value, By Region, 2019-2030, Million USD

TABLE 117.    North America Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 118.    North America  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 119.    North America  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 120.    North America Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 121.    North America Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 122.    U.S. Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 123.    U.S. Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 124.    U.S. External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 125.    U.S. Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 126.    U.S. Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 127.    Canada Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 128.    Canada Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 129.    Canada External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 130.    Canada Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 131.    Canada Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 132.    Mexico Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 133.    Mexico Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 134.    Mexico External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 135.    Mexico Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 136.    Mexico Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 137.    Europe Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 138.    Europe  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 139.    Europe  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 140.    Europe Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 141.    Europe Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 142.    Germany Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 143.    Germany Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 144.    Germany External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 145.    Germany Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 146.    Germany Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 147.    UK Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 148.    UK Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 149.    UK External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 150.    UK Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 151.    UK Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 152.    France Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 153.    France Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 154.    France External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 155.    France Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 156.    France Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 157.    Italy Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 158.    Italy Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 159.    Italy External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 160.    Italy Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 161.    Italy Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 162.    Spain Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 163.    Spain Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 164.    Spain External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 165.    Spain Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 166.    Spain Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 167.    Rest of Europe Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 168.    Rest of Europe Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 169.    Rest of Europe External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 170.    Rest of Europe Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 171.    Rest of Europe Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 172.    Asia-Pacific Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 173.    Asia-Pacific  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 174.    Asia-Pacific  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 175.    Asia-Pacific Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 176.    Asia-Pacific Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 177.    China Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 178.    China Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 179.    China External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 180.    China Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 181.    China Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 182.    India Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 183.    India Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 184.    India External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 185.    India Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 186.    India Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 187.    Japan Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 188.    Japan Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 189.    Japan External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 190.    Japan Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 191.    Japan Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 192.    South Korea Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 193.    South Korea Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 194.    South Korea External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 195.    South Korea Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 196.    South Korea Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 197.    Malaysia Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 198.    Malaysia Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 199.    Malaysia External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 200.    Malaysia Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 201.    Malaysia Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 202.    Rest of Asia-Pacific Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 203.    Rest of Asia-Pacific Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 204.    Rest of Asia-Pacific External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 205.    Rest of Asia-Pacific Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 206.    Rest of Asia-Pacific Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 207.    Rest of World Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 208.    Rest of World  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 209.    Rest of World  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 210.    Rest of World Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 211.    Rest of World Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 212.    Brazil Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 213.    Brazil Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 214.    Brazil External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 215.    Brazil Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 216.    Brazil Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 217.    Israel Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 218.    Israel Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 219.    Israel External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 220.    Israel Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 221.    Israel Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 222.    Saudi Arabia Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 223.    Saudi Arabia Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 224.    Saudi Arabia External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 225.    Saudi Arabia Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 226.    Saudi Arabia Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 227.    South Africa Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 228.    South Africa Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 229.    South Africa External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 230.    South Africa Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 231.    South Africa Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 232.    Remaining Countries Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 233.    Remaining Countries Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 234.    Remaining Countries External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

TABLE 235.    Remaining Countries Neuromodulation Market Value, By Application, 2019-2030, Million USD

TABLE 236.    Remaining Countries Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

TABLE 237.    Aleva Neurotherapeutics SA: COMPANY SNAPSHOT

TABLE 238.    Aleva Neurotherapeutics SA: OPERATING SEGMENTS

TABLE 239.    Aleva Neurotherapeutics SA: PRODUCT PORTFOLIO

TABLE 240.    Aleva Neurotherapeutics SA: KEY STRATERGY

TABLE 241.    BioControl Medical: COMPANY SNAPSHOT

TABLE 242.    BioControl Medical: OPERATING SEGMENTS

TABLE 243.    BioControl Medical: PRODUCT PORTFOLIO

TABLE 244.    BioControl Medical: KEY STRATERGY

TABLE 245.    Bioness Inc.: COMPANY SNAPSHOT

TABLE 246.    Bioness Inc.: OPERATING SEGMENTS

TABLE 247.    Bioness Inc.: PRODUCT PORTFOLIO

TABLE 248.    Bioness Inc.: KEY STRATERGY

TABLE 249.    Boston Scientific Corporation: COMPANY SNAPSHOT

TABLE 250.    Boston Scientific Corporation: OPERATING SEGMENTS

TABLE 251.    Boston Scientific Corporation: PRODUCT PORTFOLIO

TABLE 252.    Boston Scientific Corporation: KEY STRATERGY

TABLE 253.    EnteroMedics Inc.: COMPANY SNAPSHOT

TABLE 254.    EnteroMedics Inc.: OPERATING SEGMENTS

TABLE 255.    EnteroMedics Inc.: PRODUCT PORTFOLIO

TABLE 256.    EnteroMedics Inc.: KEY STRATERGY

TABLE 257.    LivaNova PLC: COMPANY SNAPSHOT

TABLE 258.    LivaNova PLC: OPERATING SEGMENTS

TABLE 259.    LivaNova PLC: PRODUCT PORTFOLIO

TABLE 260.    LivaNova PLC: KEY STRATERGY

TABLE 261.    Medtronic plc: COMPANY SNAPSHOT

TABLE 262.    Medtronic plc: OPERATING SEGMENTS

TABLE 263.    Medtronic plc: PRODUCT PORTFOLIO

TABLE 264.    Medtronic plc: KEY STRATERGY

TABLE 265.    NeuroPace, Inc.: COMPANY SNAPSHOT

TABLE 266.    NeuroPace, Inc.: OPERATING SEGMENTS

TABLE 267.    NeuroPace, Inc.: PRODUCT PORTFOLIO

TABLE 268.    NeuroPace, Inc.: KEY STRATERGY

TABLE 269.    Nevro Corporation: COMPANY SNAPSHOT

TABLE 270.    Nevro Corporation: OPERATING SEGMENTS

TABLE 271.    Nevro Corporation: PRODUCT PORTFOLIO

TABLE 272.    Nevro Corporation: KEY STRATERGY

TABLE 273.    St. Jude Medical, Inc.: COMPANY SNAPSHOT

TABLE 274.    St. Jude Medical, Inc.: OPERATING SEGMENTS

TABLE 275.    St. Jude Medical, Inc.: PRODUCT PORTFOLIO

TABLE 276.    St. Jude Medical, Inc.: KEY STRATERGY

 

 

LIST OF FIGURES

FIGURE 1.       Global  Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 2.       Global Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 3.       Deep Brain Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 4.       North America Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 5.       Europe Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 6.       Asia-Pacific Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 7.       Rest of World Deep Brain Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 8.       Sacral nerve Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 9.       North America Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 10.     Europe Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 11.     Asia-Pacific Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 12.     Rest of World Sacral nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 13.     Spinal Cord Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 14.     North America Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 15.     Europe Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 16.     Asia-Pacific Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 17.     Rest of World Spinal Cord Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 18.     Vagus Nerve Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 19.     North America Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 20.     Europe Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 21.     Asia-Pacific Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 22.     Rest of World Vagus Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 23.     Other Neuromodulation Market Value, By Region, 2019-2030, Million USD

FIGURE 24.     North America Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 25.     Europe Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 26.     Asia-Pacific Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 27.     Rest of World Other Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 28.     Internal Neuromodulation Market Value, By Region, 2019-2030, Million USD

FIGURE 29.     North America Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 30.     Europe Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 31.     Asia-Pacific Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 32.     Rest of World Internal Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 33.     Global External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 34.     Transcutaneous Electrical Nerve Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 35.     North America Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 36.     Europe Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 37.     Asia-Pacific Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 38.     Rest of World Transcutaneous Electrical Nerve Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 39.     Transcranial Magnetic Stimulation Market Value, By Region, 2019-2030, Million USD

FIGURE 40.     North America Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 41.     Europe Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 42.     Asia-Pacific Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 43.     Rest of World Transcranial Magnetic Stimulation Market Value, By Country, 2019-2030, Million USD

FIGURE 44.     External Neuromodulation Market Value, By Region, 2019-2030, Million USD

FIGURE 45.     North America External Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 46.     Europe External Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 47.     Asia-Pacific External Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 48.     Rest of World External Neuromodulation Market Value, By Country, 2019-2030, Million USD

FIGURE 49.     Global  Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 50.     Failed Back Syndrome Market Value, By Region, 2019-2030, Million USD

FIGURE 51.     North America Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 52.     Europe Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 53.     Asia-Pacific Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 54.     Rest of World Failed Back Syndrome Market Value, By Country, 2019-2030, Million USD

FIGURE 55.     Chronic Pain Market Value, By Region, 2019-2030, Million USD

FIGURE 56.     North America Chronic Pain Market Value, By Country, 2019-2030, Million USD

FIGURE 57.     Europe Chronic Pain Market Value, By Country, 2019-2030, Million USD

FIGURE 58.     Asia-Pacific Chronic Pain Market Value, By Country, 2019-2030, Million USD

FIGURE 59.     Rest of World Chronic Pain Market Value, By Country, 2019-2030, Million USD

FIGURE 60.     Epilepsy Market Value, By Region, 2019-2030, Million USD

FIGURE 61.     North America Epilepsy Market Value, By Country, 2019-2030, Million USD

FIGURE 62.     Europe Epilepsy Market Value, By Country, 2019-2030, Million USD

FIGURE 63.     Asia-Pacific Epilepsy Market Value, By Country, 2019-2030, Million USD

FIGURE 64.     Rest of World Epilepsy Market Value, By Country, 2019-2030, Million USD

FIGURE 65.     Essential Tremor Market Value, By Region, 2019-2030, Million USD

FIGURE 66.     North America Essential Tremor Market Value, By Country, 2019-2030, Million USD

FIGURE 67.     Europe Essential Tremor Market Value, By Country, 2019-2030, Million USD

FIGURE 68.     Asia-Pacific Essential Tremor Market Value, By Country, 2019-2030, Million USD

FIGURE 69.     Rest of World Essential Tremor Market Value, By Country, 2019-2030, Million USD

FIGURE 70.     Urinary and Fecal Incontinence Market Value, By Region, 2019-2030, Million USD

FIGURE 71.     North America Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

FIGURE 72.     Europe Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

FIGURE 73.     Asia-Pacific Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

FIGURE 74.     Rest of World Urinary and Fecal Incontinence Market Value, By Country, 2019-2030, Million USD

FIGURE 75.     Depression Market Value, By Region, 2019-2030, Million USD

FIGURE 76.     North America Depression Market Value, By Country, 2019-2030, Million USD

FIGURE 77.     Europe Depression Market Value, By Country, 2019-2030, Million USD

FIGURE 78.     Asia-Pacific Depression Market Value, By Country, 2019-2030, Million USD

FIGURE 79.     Rest of World Depression Market Value, By Country, 2019-2030, Million USD

FIGURE 80.     Dystonia Market Value, By Region, 2019-2030, Million USD

FIGURE 81.     North America Dystonia Market Value, By Country, 2019-2030, Million USD

FIGURE 82.     Europe Dystonia Market Value, By Country, 2019-2030, Million USD

FIGURE 83.     Asia-Pacific Dystonia Market Value, By Country, 2019-2030, Million USD

FIGURE 84.     Rest of World Dystonia Market Value, By Country, 2019-2030, Million USD

FIGURE 85.     Gastroparesis Market Value, By Region, 2019-2030, Million USD

FIGURE 86.     North America Gastroparesis Market Value, By Country, 2019-2030, Million USD

FIGURE 87.     Europe Gastroparesis Market Value, By Country, 2019-2030, Million USD

FIGURE 88.     Asia-Pacific Gastroparesis Market Value, By Country, 2019-2030, Million USD

FIGURE 89.     Rest of World Gastroparesis Market Value, By Country, 2019-2030, Million USD

FIGURE 90.     Parkinson's Disease Market Value, By Region, 2019-2030, Million USD

FIGURE 91.     North America Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

FIGURE 92.     Europe Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

FIGURE 93.     Asia-Pacific Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

FIGURE 94.     Rest of World Parkinson's Disease Market Value, By Country, 2019-2030, Million USD

FIGURE 95.     Migraine Market Value, By Region, 2019-2030, Million USD

FIGURE 96.     North America Migraine Market Value, By Country, 2019-2030, Million USD

FIGURE 97.     Europe Migraine Market Value, By Country, 2019-2030, Million USD

FIGURE 98.     Asia-Pacific Migraine Market Value, By Country, 2019-2030, Million USD

FIGURE 99.     Rest of World Migraine Market Value, By Country, 2019-2030, Million USD

FIGURE 100.  Global  Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 101.  Ceramics Biomaterials Market Value, By Region, 2019-2030, Million USD

FIGURE 102.  North America Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 103.  Europe Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 104.  Asia-Pacific Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 105.  Rest of World Ceramics Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 106.  Metallic Biomaterials Market Value, By Region, 2019-2030, Million USD

FIGURE 107.  North America Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 108.  Europe Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 109.  Asia-Pacific Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 110.  Rest of World Metallic Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 111.  Polymeric Biomaterials Market Value, By Region, 2019-2030, Million USD

FIGURE 112.  North America Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 113.  Europe Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 114.  Asia-Pacific Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 115.  Rest of World Polymeric Biomaterials Market Value, By Country, 2019-2030, Million USD

FIGURE 116.  Global  Neuromodulation Market Value, By Region, 2019-2030, Million USD

FIGURE 117.  North America Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 118.  North America  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 119.  North America  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 120.  North America Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 121.  North America Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 122.  U.S. Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 123.  U.S. Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 124.  U.S. External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 125.  U.S. Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 126.  U.S. Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 127.  Canada Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 128.  Canada Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 129.  Canada External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 130.  Canada Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 131.  Canada Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 132.  Mexico Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 133.  Mexico Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 134.  Mexico External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 135.  Mexico Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 136.  Mexico Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 137.  Europe Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 138.  Europe  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 139.  Europe  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 140.  Europe Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 141.  Europe Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 142.  Germany Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 143.  Germany Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 144.  Germany External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 145.  Germany Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 146.  Germany Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 147.  UK Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 148.  UK Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 149.  UK External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 150.  UK Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 151.  UK Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 152.  France Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 153.  France Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 154.  France External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 155.  France Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 156.  France Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 157.  Italy Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 158.  Italy Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 159.  Italy External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 160.  Italy Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 161.  Italy Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 162.  Spain Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 163.  Spain Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 164.  Spain External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 165.  Spain Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 166.  Spain Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 167.  Rest of Europe Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 168.  Rest of Europe Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 169.  Rest of Europe External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 170.  Rest of Europe Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 171.  Rest of Europe Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 172.  Asia-Pacific Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 173.  Asia-Pacific  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 174.  Asia-Pacific  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 175.  Asia-Pacific Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 176.  Asia-Pacific Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 177.  China Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 178.  China Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 179.  China External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 180.  China Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 181.  China Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 182.  India Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 183.  India Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 184.  India External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 185.  India Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 186.  India Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 187.  Japan Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 188.  Japan Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 189.  Japan External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 190.  Japan Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 191.  Japan Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 192.  South Korea Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 193.  South Korea Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 194.  South Korea External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 195.  South Korea Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 196.  South Korea Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 197.  Malaysia Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 198.  Malaysia Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 199.  Malaysia External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 200.  Malaysia Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 201.  Malaysia Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 202.  Rest of Asia-Pacific Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 203.  Rest of Asia-Pacific Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 204.  Rest of Asia-Pacific External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 205.  Rest of Asia-Pacific Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 206.  Rest of Asia-Pacific Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 207.  Rest of World Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 208.  Rest of World  Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 209.  Rest of World  External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 210.  Rest of World Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 211.  Rest of World Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 212.  Brazil Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 213.  Brazil Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 214.  Brazil External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 215.  Brazil Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 216.  Brazil Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 217.  Israel Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 218.  Israel Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 219.  Israel External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 220.  Israel Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 221.  Israel Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 222.  Saudi Arabia Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 223.  Saudi Arabia Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 224.  Saudi Arabia External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 225.  Saudi Arabia Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 226.  Saudi Arabia Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 227.  South Africa Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 228.  South Africa Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 229.  South Africa External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 230.  South Africa Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 231.  South Africa Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 232.  Remaining Countries Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 233.  Remaining Countries Internal Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 234.  Remaining Countries External Neuromodulation Market Value, By Technology, 2019-2030, Million USD

FIGURE 235.  Remaining Countries Neuromodulation Market Value, By Application, 2019-2030, Million USD

FIGURE 236.  Remaining Countries Neuromodulation Market Value, By Biomaterial, 2019-2030, Million USD

FIGURE 237.  Aleva Neurotherapeutics SA: NET SALES,2017-2019

FIGURE 238.  BioControl Medical: NET SALES,2017-2019

FIGURE 239.  Bioness Inc.: NET SALES,2017-2019

FIGURE 240.  Boston Scientific Corporation: NET SALES,2017-2019

FIGURE 241.  EnteroMedics Inc.: NET SALES,2017-2019

FIGURE 242.  LivaNova PLC: NET SALES,2017-2019

FIGURE 243.  Medtronic plc: NET SALES,2017-2019

FIGURE 244.  NeuroPace, Inc.: NET SALES,2017-2019

FIGURE 245.  Nevro Corporation: NET SALES,2017-2019

FIGURE 246.  St. Jude Medical, Inc.: NET SALES,2017-2019

KEY PLAYERS:

  • St. Jude Medical, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Boston Scientific Corporation
  • BioControl Medical
  • Bioness Inc.
  • EnteroMedics Inc.
  • NeuroPace Inc
  • Aleva Neurotherapeutics SA
  • Nevro Corporation

Frequently Asked Questions
What will be the worth of global Neuromodulation Market by the end of 2030?

According to the report published by Next Move Strategy Consulting, the Neuromodulation market business is expected to hit at $22.19 billion (USD) by 2030.

Which region is expected to hold the highest market share in the Neuromodulation Market?

North America is expected to hold the highest market share in the global market. The region is expected to witness remarkable growth as it houses the major key players in the market.

Which are the top companies in the Neuromodulation industry?

Abbott, Medtronic, Boston Scientific Corporation, Cochlear Ltd., Cyberonics Inc., Sonova, Nevro Corp., Advanced Bionics AG, Integer Holdings Corporation, Neuronetics, NeuroPace Inc., Synapse Biomedical Inc., Magstim, NeuroSigma Inc., LivaNova PLC, Soterix Medical Inc., ALEVA NEUROTHERAPEUTICS SA, ReShape Lifesciences Inc., Bioness Inc., DynaMD, BioAlps, MED-EL, The Axonics SNM System, Johnson & Johnson Services Inc., LABORIE, Stimwave LLC, Functional Neuromodulation Ltd., and Biegler GmbH

What are the market segmentations and scope of the study?

The global Neuromodulation market share is analyzed on the basis of technology, application, biomaterial, and geography.

How big is the Neuromodulation market?

Currently (in 2019), the market value stands at USD 5.90 billion and it is anticipated to reach USD 22.19 billion by 2030.